Search - tctmd.com

Displaying 841 - 860 of 1638

Sort: Relevancy | Date

News Daily News

Large, US Study Supports Single High-Sensitivity Troponin I Test for Suspected Acute MI

Todd Neale

July 16, 2019

Presentation SCCT 2019

Patients with High-risk of CAD But No Known CAD Should Go to CTA First Versus Functional Test First

Presenter: David Newby

July 11, 2019

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

News Daily News

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Yael L. Maxwell

July 04, 2019

News Opinion Fellow Talk

Hemodynamics: The Forgotten Branch of Cardiology

Mesfer Alfadhel, MD

June 28, 2019

News Daily News

Tool May Ease Use of High-Sensitivity Troponin for Acute MI Diagnosis

Todd Neale

June 28, 2019

News Daily News

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

Todd Neale

June 26, 2019

News Daily News

Ischemic Events Worsen Long-term Cognitive Decline

Yael L. Maxwell

June 18, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Daily News

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

Caitlin E. Cox

June 13, 2019

News Daily News

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

Caitlin E. Cox

June 12, 2019

News Conference News EuroPCR 2019

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

L.A. McKeown

June 07, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Conference News EuroPCR 2019

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Caitlin E. Cox

June 06, 2019

News Conference News EAS 2019

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

Michael O'Riordan

June 05, 2019

News Conference News SCAI 2019

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Yael L. Maxwell

June 04, 2019

News Conference News EAS 2019

Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION

Michael O'Riordan

June 04, 2019

News Conference News SCAI 2019

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Yael L. Maxwell

June 03, 2019

News Conference News EAS 2019

FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis

Michael O'Riordan

June 03, 2019

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

Advertisement

Large, US Study Supports Single High-Sensitivity Troponin I Test for Suspected Acute MI

Patients with High-risk of CAD But No Known CAD Should Go to CTA First Versus Functional Test First

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

Age Without Atherosclerosis: Tests May Help Elderly Skip Statins

Hemodynamics: The Forgotten Branch of Cardiology

Tool May Ease Use of High-Sensitivity Troponin for Acute MI Diagnosis

Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues

Ischemic Events Worsen Long-term Cognitive Decline

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Platelet Function and Genetic Testing to Guide P2Y12 Inhibitor Meds in PCI: Updated Consensus

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Early Days With OCT-Derived FFR Technology, but New Data Suggest Promise

Absence of FH Diagnosis Linked to Increased Risk of Premature Mortality

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content